Skip to content

Effect of Dexmedetomidine in Urologic Surgery

Analysis of sedation onset time in Alpha adrenergic blocker using patients with spinal anesthesia and dexmedetomidine

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
CRIS
Registry ID
KCT0002967
Enrollment
100
Registered
2018-07-02
Start date
2018-05-09
Completion date
Unknown
Last updated
2019-03-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Procedure/Surgery : Dexmedetomidine is administered via intravenous route at a dose of 1 ug/kg for 10 minutes and then 1 ug/ kg/hr until the end of the operation.

Sponsors

Pusan National University Hospital
Lead Sponsor

Eligibility

Sex/Gender
Male

Inclusion criteria

Inclusion criteria: 1. Patients who require spinal anesthesia and planned sedation among the patients for treatment of prostatic disease 2. Patients from 20 to 70 years of age who have no systemic disease or systemic disease but are mild 3. The basic monitoring device (blood pressure, electrocardiogram, pulse oxygen saturation) and BIS attachment is possible

Exclusion criteria

Exclusion criteria: 1. Patient whose operation time is within 30 minutes 2. Patients who have had previous side effects after sedation 3. Patients with severe cardiopulmonary dysfunction 4. Patients with liver, kidney disease, alcohol or drug overdose 5. Patients with mental disorders or brain lesions

Design outcomes

Primary

MeasureTime frame
Modified Observer's Assessment of Alertness/Sedation;Bispectral index monitor

Secondary

MeasureTime frame
Blood pressure, Heart rate, Oxygen saturation

Countries

Korea, Republic of

Contacts

Public ContactDowon Lee

Pusan National University Hospital

drldw03@naver.com+82-51-240-7399

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: Mar 5, 2026